Search

Author/Creator Fura, Aberra

1. Discovery of highly potent, selective, covalent inhibitors of JAK3. Issue 20 (15th October 2017)

Authors:
Kempson, James; Ovalle, Damaso; Guo, Junqing; Wrobleski, Stephen T.; Lin, Shuqun; Spergel, Steven H.; Duan, James J.-W.; Jiang, Bin; Lu, Zhonghui; Das, Jagabandhu; Yang, Bingwei V.; Hynes, John; Wu, Hong; Tokarski, John; Sack, John S.; Khan, Javed; Schieven, Gary; Blatt, Yuval; Chaudhry, Charu; S...
Journal:
Bioorganic & medicinal chemistry letters
Issue:
Volume 27:Issue 20(2017)
Page Start:
4622
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Discovery of potent and efficacious pyrrolopyridazines as dual JAK1/3 inhibitors. Issue 14 (15th July 2017)

Authors:
Hynes, John; Wu, Hong; Kempson, James; Duan, James J.-W.; Lu, Zhonghui; Jiang, Bin; Stachura, Sylwia; Tokarski, John S.; Sack, John S.; Khan, Javed A.; Lippy, Jonathan S.; Zhang, Rosemary F.; Pitt, Sidney; Shen, Guoxiang; Gillooly, Kate; McIntyre, Kim; Carter, Percy H.; Barrish, Joel C.; Nadler, ...
Journal:
Bioorganic & medicinal chemistry letters
Issue:
Volume 27:Issue 14(2017)
Page Start:
3101
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Evaluation of BMS-986142, a reversible Bruton's tyrosine kinase inhibitor, for the treatment of rheumatoid arthritis: a phase 2, randomised, double-blind, dose-ranging, placebo-controlled, adaptive design study. (May 2023)

Authors:
Conaghan, Philip G; Nowak, Miroslawa; Du, Shuyan; Luo, Yi; Landis, Jessica; Pachai, Chahin; Fura, Aberra; Catlett, Ian M; Grasela, Dennis M; Østergaard, Mikkel
Journal:
Lancet
Issue:
Volume 5:Number 5(2023)
Page Start:
e263
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Population Pharmacokinetic Analysis of BMS‐986166, a Novel Selective Sphingosine‐1‐Phosphate‐1 Receptor Modulator, and Exposure‐Response Assessment of Lymphocyte Counts and Heart Rate in Healthy Participants. Issue 1 (8th October 2020)

Authors:
Bihorel, Sébastien; Singhal, Shalabh; Shevell, Diane; Sun, Huadong; Xie, Jenny; Basdeo, Shenita; Liu, Ang; Dutta, Santanu; Ludwig, Elizabeth; Huang, Hannah; Lin, Kuan‐ju; Fura, Aberra; Throup, John; Girgis, Ihab G.
Journal:
Clinical pharmacology in drug development
Issue:
Volume 10:Issue 1(2021)
Page Start:
8
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. The discovery of BMS-737 as a potent, CYP17 lyase-selective inhibitor for the treatment of castration-resistant prostate cancer. (1st November 2022)

Authors:
Padmakar Darne, Chetan; Velaparthi, Upender; Saulnier, Mark; Frennesson, David; Liu, Peiying; Huang, Audris; Tokarski, John; Fura, Aberra; Spires, Thomas; Newitt, John; Spires, Vanessa M.; Obermeier, Mary T.; Elzinga, Paul A.; Gottardis, Marco M.; Jayaraman, Lata; Vite, Gregory D.; Balog, Aaron
Journal:
Bioorganic & medicinal chemistry letters
Issue:
Volume 75(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Tricyclic sulfones as potent, selective and efficacious RORγt inverse agonists – Exploring C6 and C8 SAR using late-stage functionalization. Issue 23 (1st December 2020)

Authors:
Shi, Qing; Xiao, Zili; Yang, Michael G.; Marcoux, David; Cherney, Robert J.; Yip, Shiuhang; Li, Peng; Wu, Dauh-Rurng; Weigelt, Carolyn A.; Sack, John; Khan, Javed; Ruzanov, Max; Wang, Jinhong; Yarde, Melissa; Ellen Cvijic, Mary; Li, Sha; Shuster, David J.; Xie, Jenny; Sherry, Tara; Obermeier, Mary
Journal:
Bioorganic & medicinal chemistry letters
Issue:
Volume 30:Issue 23(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗